Nautilus Biotechnology, Inc. Profile Avatar - Palmy Investing

Nautilus Biotechnology, Inc.

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end…

Biotechnology
US, Seattle [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of NAUT's Analysis
CIK: 1808805 CUSIP: 63909J108 ISIN: US63909J1088 LEI: - UEI: -
Secondary Listings
NAUT has no secondary listings inside our databases.